Danaila, Mihai Cosmin
Danaila, Mihai Cosmin
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study
2019 Elhai, M.; Boubaya, M.; Distler, O.; Smith, V.; Matucci-Cerinic, M.; Alegre Sancho, J. J.; Truchetet, M. -E.; Braun-Moscovici, Y.; Iannone, Federico; Novikov, P. I.; Lescoat, A.; Siegert, E.; Castellvi, I.; Airo, P.; Vettori, Silvia; De Langhe, E.; Hachulla, E.; Erler, A.; Ananieva, L.; Krusche, M.; Lopez-Longo, F. J.; Distler, J. H. W.; Hunzelmann, N.; Hoffmann-Vold, A. -M.; Riccieri, V.; Hsu, V. M.; Pozzi, M. R.; Ancuta, C.; Rosato, E.; Danaila, Mihai Cosmin; Kuwana, M.; Saketkoo, L. A.; Chizzolini, C.; Hesselstrand, R.; Ullman, S.; UGUR YAVUZ, Secil; Rednic, S.; Caimmi, C.; Bloch-Queyrat, C.; Allanore, Y.
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
2019 Fasano, Silvia; Riccardi, A.; Messiniti, V.; Caramaschi, P.; Rosato, E.; Maurer, B.; Smith, V.; Siegert, E.; De Langhe, E.; Riccieri, V.; Airo, P.; Mihai, C.; Avouac, J.; Zanatta, E.; Walker, U. A.; Iannone, F.; De La Pena Lefebvre, P. G.; Distler, J. H. W.; Vacca, A.; Distler, O.; Kowal-Bielecka, O.; Allanore, Y.; Valentini, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study | 2019 | Elhai, M.; Boubaya, M.; Distler, O.; Smith, V.; Matucci-Cerinic, M.; Alegre Sancho, J. J.; Truchetet, M. -E.; Braun-Moscovici, Y.; Iannone, Federico; Novikov, P. I.; Lescoat, A.; Siegert, E.; Castellvi, I.; Airo, P.; Vettori, Silvia; De Langhe, E.; Hachulla, E.; Erler, A.; Ananieva, L.; Krusche, M.; Lopez-Longo, F. J.; Distler, J. H. W.; Hunzelmann, N.; Hoffmann-Vold, A. -M.; Riccieri, V.; Hsu, V. M.; Pozzi, M. R.; Ancuta, C.; Rosato, E.; Danaila, Mihai Cosmin; Kuwana, M.; Saketkoo, L. A.; Chizzolini, C.; Hesselstrand, R.; Ullman, S.; UGUR YAVUZ, Secil; Rednic, S.; Caimmi, C.; Bloch-Queyrat, C.; Allanore, Y. | |
| Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual | 2019 | Fasano, Silvia; Riccardi, A.; Messiniti, V.; Caramaschi, P.; Rosato, E.; Maurer, B.; Smith, V.; Siegert, E.; De Langhe, E.; Riccieri, V.; Airo, P.; Mihai, C.; Avouac, J.; Zanatta, E.; Walker, U. A.; Iannone, F.; De La Pena Lefebvre, P. G.; Distler, J. H. W.; Vacca, A.; Distler, O.; Kowal-Bielecka, O.; Allanore, Y.; Valentini, G. |